Covid-19 and Cancer - Publications and abstracts list from taskforce members including the recent Lancet Oncology publication "Cancer and COVID-19 vaccines: a complex global picture" available via the link below.
Covid-19 and Cancer intelligence hub, hosted by ecancer: Rapid reports are critical for getting data in the public domain in these unprecedented times. The intelligence hub serves as a single point of access to current literature, current impact case studies and emerging reports. We encourage you to contribute.
Group members are engaged in wide variety of research projects investigating the impact of the COVID-19 crisis on Cancer:
The COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. Our aim is to help to configure modelling platforms and teams that can provide more informed advice to our governments, particularly those in low- and middle-income countries, as they rise to this overwhelming health systems challenge. Our focus on the longer-term, as well as the shorter-term, recognises that recovery strategies will be required as countries move beyond the acute phase of the crisis. See more for the details of the three areas of work we are prioritizing.
A series of webinars from the taskforce members covering the latest developments in covid and cancer
The coronavirus (COVID-19) pandemic has created massive downward pressure on social, economic and health systems across the world. Cancer patients in all countries and settings have been directly and indirectly impacted.
The Covid-19 and Cancer Global Taskforce is an internationally representative group of cancer leaders set up in Feb 2020 with many leading senior clinicians, spanning the cancer care continuum from high income settings to many of the most complex and resource constrained countries in the world.
Through wide ranging collaborations the Taskforce has delivered over a hundred research publications on the management of cancer patients and the mitigation of the pandemic on cancer care. In addition to the extensive research portfolio there has been an active education and dissemination program through webinars and clinical case teaching.
As a collective dedicated to cancer care and control during pandemic waves and planning future mitigation and resilience strategies, we are always open to new members who are interested in research to policy.